Screening for prostate cancer
Background Any form of screening aims to reduce disease‐specific and overall mortality,
and to improve a person's future quality of life. Screening for prostate cancer has generated …
and to improve a person's future quality of life. Screening for prostate cancer has generated …
Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials
Background: Several popular screening tests, such as mammography and prostate-specific
antigen, have met with wide controversy and/or have lost their endorsement recently. We …
antigen, have met with wide controversy and/or have lost their endorsement recently. We …
Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada
J Smith-Palmer, C Takizawa, W Valentine - BMC urology, 2019 - Springer
Background Prostate cancer is the most frequently reported cancer in males in Europe, and
is associated with substantial morbidity and mortality. The aim of the current review was to …
is associated with substantial morbidity and mortality. The aim of the current review was to …
[HTML][HTML] Prostate cancer: ESMO consensus conference guidelines 2012
A Horwich, J Hugosson, T de Reijke, T Wiegel… - Annals of oncology, 2013 - Elsevier
Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …
Modifiable risk factors for prostate cancer in low-and lower-middle-income countries: a systematic review and meta-analysis
F Cirne, C Kappel, S Zhou, SD Mukherjee… - Prostate Cancer and …, 2022 - nature.com
Background Most of the epidemiological data on prostate cancer risk factors come from high-
income countries (HIC). Reducing exposure to prostate cancer modifiable risk factors may …
income countries (HIC). Reducing exposure to prostate cancer modifiable risk factors may …
Data-independent acquisition mass spectrometry of EPS-urine coupled to machine learning: a predictive model for prostate cancer
LE Prestagiacomo, G Tradigo, F Aracri, C Gabriele… - ACS …, 2023 - ACS Publications
Prostate cancer (PCa) is annually the most frequently diagnosed cancer in the male
population. To date, the diagnostic path for PCa detection includes the dosage of serum …
population. To date, the diagnostic path for PCa detection includes the dosage of serum …
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
Most prostate cancers (PC) are currently found on the basis of an elevated PSA, although
this biomarker has only moderate accuracy. Histological confirmation is traditionally …
this biomarker has only moderate accuracy. Histological confirmation is traditionally …
Cytoreductive prostatectomy for metastatic prostate cancer: first lessons learned from the multicentric prospective local treatment of metastatic prostate cancer (LoMP) …
F Poelaert, C Verbaeys, B Rappe, B Kimpe, I Billiet… - Urology, 2017 - Elsevier
Objective To prospectively evaluate patients with newly diagnosed metastatic prostate
cancer in the context of the LoMP trial (which investigates the role of cytoreductive radical …
cancer in the context of the LoMP trial (which investigates the role of cytoreductive radical …
[HTML][HTML] Prostate-specific antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
G Pron - Ontario health technology assessment series, 2015 - ncbi.nlm.nih.gov
Background Prostate cancer (PC) is the most commonly diagnosed non-cutaneous cancer
in men and their second or third leading cause of cancer death. Prostate-specific antigen …
in men and their second or third leading cause of cancer death. Prostate-specific antigen …
Mass spectrometry-based glycoproteomics and prostate cancer
C Gabriele, LE Prestagiacomo, G Cuda… - International Journal of …, 2021 - mdpi.com
Aberrant glycosylation has long been known to be associated with cancer, since it is
involved in key mechanisms such as tumour onset, development and progression. This …
involved in key mechanisms such as tumour onset, development and progression. This …